Skip to main content
. 2017 Oct 24;61(11):e01045-17. doi: 10.1128/AAC.01045-17

TABLE 1.

Antimicrobial activity of ceftazidime-avibactam tested against antimicrobial resistant Enterobacteriaceae and P. aeruginosa from U.S. hospitals (2013 to 2016)a

Organism (no. of isolates) No. of isolates and cumulative % at various MICs (μg/ml)b
MIC (μg/ml)
≤0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 >32 MIC50 MIC90
Enterobacteriaceae (36,380) 1,334 4,428 11,139 12,342 4,815 1,631 448 142 63 15 13 1 9 0.12 0.25
3.7 15.8 46.5 80.4 93.6 98.1 99.3 99.7 99.9 99.9 >99.9 >99.9 100.0
    CRE (513) 16 5 13 35 76 137 138 59 20 1 4 0 9 0.5 2
3.1 4.1 6.6 13.5 28.3 55.0 81.9 93.4 97.3 97.5 98.2 98.2 100.0
    MDR (2,953) 98 217 428 597 587 525 296 116 53 13 13 1 9 0.25 1
3.3 10.7 25.2 45.4 65.3 83.0 93.1 97.0 98.8 99.2 99.7 99.7 100.0
    XDR (448) 16 9 20 25 53 126 117 44 23 5 4 0 6 0.5 2
3.6 5.6 10.0 15.6 27.5 55.6 81.7 91.5 96.7 97.8 98.7 98.7 100.0
E. coli (12,942) 1,024 1,463 4,597 4,550 1,066 186 36 13 3 1 0 0 3 0.06 0.25
7.9 19.2 54.7 89.9 98.1 99.6 99.8 99.9 >99.9 >99.9 >99.9 >99.9 100.0
    Ceftriaxone-NS (1,750) 100 63 247 736 444 108 33 12 3 1 0 0 3 0.12 0.25
5.7 9.3 23.4 65.5 90.9 97.0 98.9 99.6 99.8 99.8 99.8 99.8 100.0
    MEM-NS (27) 1 1 3 5 8 4 1 1 0 0 0 0 3 0.25 >32
3.7 7.4 18.5 37.0 66.7 81.5 85.2 88.9 88.9 88.9 88.9 88.9 100.0
K. pneumoniae (7,511) 137 364 2,523 2,950 957 364 137 58 17 0 1 0 3 0.12 0.25
1.8 6.7 40.3 79.5 92.3 97.1 98.9 99.7 99.9 99.9 >99.9 >99.9 100.0
    MEM-NS (382) 15 5 7 21 56 111 99 48 16 0 1 0 3 0.5 2
3.9 5.2 7.1 12.6 27.2 56.3 82.2 94.8 99.0 99.0 99.2 99.2 100.0
    Ceftriaxone-NS (1,063) 39 23 67 259 242 229 127 56 17 0 1 0 3 0.25 1
3.7 5.8 12.1 36.5 59.3 80.8 92.8 98.0 99.6 99.6 99.7 99.7 100.0
    Colistin-NS (205) 9 4 22 49 30 36 32 13 9 0 0 0 1 0.25 2
4.4 6.3 17.1 41.0 55.6 73.2 88.8 95.1 99.5 99.5 99.5 99.5 100.0
K. oxytoca (1,902) 8 93 823 709 174 74 14 5 1 1 0.12 0.25
0.4 5.3 48.6 85.9 95.0 98.9 99.6 99.9 99.9 100.0
Proteus mirabilis (2,818) 42 1,568 1,102 83 14 3 3 0 1 1 0 0 1 0.03 0.06
1.5 57.1 96.2 99.2 99.7 99.8 99.9 99.9 99.9 >99.9 >99.9 >99.9 100.0
E. cloacae (3,740) 33 26 215 1,594 1,184 477 164 33 8 0 3 1 2 0.25 0.5
0.9 1.6 7.3 49.9 81.6 94.4 98.7 99.6 99.8 99.8 99.9 99.9 100.0
    CAZ-NS (831) 13 3 7 44 229 345 146 30 8 0 3 1 2 0.5 1
1.6 1.9 2.8 8.1 35.6 77.1 94.7 98.3 99.3 99.3 99.6 99.8 100.0
E. aerogenes (1,384) 29 47 352 605 256 75 10 4 5 0 1 0.12 0.25
2.1 5.5 30.9 74.6 93.1 98.6 99.3 99.6 99.9 99.9 100.0
    CAZ-NS (279) 10 7 17 64 113 49 9 4 5 0 1 0.25 0.5
3.6 6.1 12.2 35.1 75.6 93.2 96.4 97.8 99.6 99.6 100.0
Morganella morganii (1,059) 2 370 489 120 40 25 9 2 1 0 1 0.06 0.12
0.2 35.1 81.3 92.6 96.4 98.8 99.6 99.8 99.9 99.9 100.0
Citrobacter koseri (777) 34 94 373 205 60 10 0 1 0.06 0.12
4.4 16.5 64.5 90.9 98.6 99.9 99.9 100.0
Citrobacter freundii (1,026) 12 15 171 473 225 98 23 2 6 1 0.12 0.5
1.2 2.6 19.3 65.4 87.3 96.9 99.1 99.3 99.9 100.0
Serratia marcescens (1,715) 4 49 720 668 233 31 5 1 2 2 0.25 0.5
0.2 3.1 45.1 84.0 97.6 99.4 99.7 99.8 99.9 100.0
Proteus vulgaris (418) 3 186 185 38 2 4 0.06 0.12
0.7 45.2 89.5 98.6 99.0 100.0
Providencia spp. (872) 5 164 184 231 149 74 14 19 18 9 5 0.12 0.5
0.6 19.4 40.5 67.0 84.1 92.5 94.2 96.3 98.4 99.4 100.0
P. aeruginosa (7,868) 141 388 2,771 2,779 1,137 426 134 43 49 2 4
1.8 6.7 41.9 77.3 91.7 97.1 98.8 99.4 100.0
    CAZ-NS (1,204) 1 1 7 93 317 344 216 133 43 49 4 16
0.1 0.2 0.7 8.5 34.8 63.4 81.3 92.4 95.9 100.0
    MEM-NS (1,471) 4 8 121 382 485 282 107 37 45 4 16
0.3 0.8 9.0 35.0 68.0 87.2 94.4 96.9 100.0
    P-T-NS (1,497) 2 1 15 108 360 467 336 125 39 44 4 16
0.1 0.2 1.2 8.4 32.5 63.7 86.1 94.5 97.1 100.0
    CAZ, MEM, and P-T-NS (628) 22 106 174 149 101 35 41 8 32
3.5 20.4 48.1 71.8 87.9 93.5 100.0
    MDR (1,562) 8 18 129 384 498 314 122 42 47 4 16
0.5 1.7 9.9 34.5 66.4 86.5 94.3 97.0 100.0
    XDR (717) 1 0 1 32 126 190 194 93 36 44 8 32
0.1 0.1 0.3 4.7 22.3 48.8 75.9 88.8 93.9 100.0
a

Abbreviations: CRE, carbapenem-resistant Enterobacteriaceae; MDR, multidrug resistant; XDR, extensively drug resistant; NS, nonsusceptible; MEM, meropenem; CAZ, ceftazidime; P-T, piperacillin-tazobactam.

b

For each entry in column 1, there are two rows of data. The first row indicates the number of strains, and the second row indicates the cumulative percentage. Column subheadings specify the various MICs in μg/ml.